Personalizing induction therapy in kidney transplantation

Meredith J. Aull, Manikkam Suthanthiran

Research output: Contribution to journalShort survey

2 Citations (Scopus)


Induction therapy with rabbit anti-thymocyte globulin is preferable to induction with daclizumab in renal transplant recipients at high immunological risk. These findings provide additional support to the idea that personalized immunosuppressive regimens should be developed in renal transplant recipients.

Original languageEnglish
Pages (from-to)619-620
Number of pages2
JournalNature Reviews Nephrology
Issue number11
Publication statusPublished - 1 Nov 2009


ASJC Scopus subject areas

  • Nephrology

Cite this